Balkan Journal of Medical Genetics

1. Cortes J, Kantarjian H. Acute lymphoblastic leukemia: a comprehensive review with emphasis on biology and therapy. Cancer 1995; 76(12): 2393-2417.

2. Pasparakis M, Alexopoulou L, Episkopou V, Kollias G. Immune and inflammatory responses in TNFa-deficient mice: a critical requirement for TNFa in the formation of primary B cell follicles, follicular dendritic network and germinal centers, and in the maturation of the humoral immune response. J Exp Med 1996; 184(4): 1397-1411.

3. Salles G, Bienvenu J, Bastion Y, Barbier Y, Doche C, Warzocha K, Gutowski M, Rieux C, Coiffier B. Elevated circulating levels of TNFa and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients. Br J Hematol 1996; 93(2): 352-359.

4. Tracey K, Wei H, Manoque K, Fong Y, Hesse D, Nguyen H, Kuo G, Beutler B, Cotran R, Cerami A. Cachectin/tumor necrosis factor induses cachexia, anemia, and inflammation. J Exp Med 1988; 167(3): 1211-1227.

5. Warzocha K, Salles G, Bienvenu j, Bastion Y, Dumontet C, Renard N, Neidhard E, Coiffier B. The tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients. J Clin Oncol 1997; 15(2):499-508.

6. Wilson A, de Vries N, Pociot F, di Giovine F, van der Putte L, Duff G. An allelic polymorphism within the human tumor necrosis factor a promoter region in strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993; 177(2): 557-560.

7. Wilson A, Symons J, McDowell T, McDevitt H, Duff G. Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94(7): 3195-3199.

8. Messer G, Spengler U, Jung MC, Honold G, Blomer K, Pape GR, Riethmuller G, Weiss EH. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 1991; 173(1): 209-219.

9. Mathew C. The isolation of high molecular weight eucariotic DNA. Meth Mol Biol 1984; 2: 31-34.

10. Stuber F, Udalova I, Book M, Drutskaya L, Kuprash D, Turetskaya R, Schade F, Nedospasov S. –308 Tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J Inflamm 1995-96; 46(1): 42-50.

11. Day C, Grove J, Daly A, Stewart M, Avery P, Walker M. Tumor necrosis factor-a gene promoter polymorphism and decreased insulin resistance. Diabetologia 1998; 41(4): 430-434.

12. Warzocha K, Ribeiro P, Bienvenu J, Roy P, Charlot C, Rigal D, Coiffier B, Salles G. Genetic polymorphisms in the tumor necrosis factor locus influence Non-Hodgkin’s lymphoma outcome. Blood 1998; 91(10): 3574-3581.

13. Roff D, Bentzen P. The statistical analysis of mitochondrial DNA: c² and problem of small samples. Mol Biol Evol 1989; 6(5): 539-545.

14. Takashiba S, Shapira L, Amar S, Van Dyke T. Cloning and characterization of human TNFa promoter region. Gene 1993; 131(2): 307-308.

15. Kroeger K, Abraham L. Identification of an AP-2 element in the –323 to –285 region of the TNF-a gene. Biochem Mol Biol Int 1996; 40(1):43-51.

16. Stanulla M, Schrauder A, Welte K, Schrappe M. Tumor necrosis factor and lymphotoxine-a genetic polymorphisms and risk of relapse in childhood b-cell precursor acute lymphoblastic leukemia: a case-control study of patients treated with BFM therapy. BMC Blood Disorders 2001; 1(1):2.

17. Takeuchi S, Takeuchi N, Tsukasaki K, Bartram C, Zimmermann M, Schrappe M, Taguchi H, Koefeler H. Genetic polymorphisms in the tumor necrosis factor locus in childhood acute lymphoblastic leukemia. Br J Haematol 2002; 119(4): 985-987.